Editor(s):
(1) Dr. Paola Angelini, University of Perugia, Italy.
(2) Dr. S. Prabhu, Sri Venkateswara College of Engineering, India.
(3) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems, Propharmex Company, India.
(4) Dr. Arun Singh, Professor, Rohilkhand Medical College & Hospital, India.
Reviewers:
(1) Nadia Noreen, Pakistan.
(2) Claudio Gambardella, The University of Campania Luigi Vanvitelli, Italy.
(3) Hojat Rashidi Jahan, Baqiyatallah University of Medical Sciences, Iran.
(4) Shan Sasidharan, India.
Additional Reviewers:
(1) Bouharati Khaoula, Constantine University, Algeria.
(2) Ibnu Sina Chandranegara, University of Muhammadiyah Jakarta, Indonesia
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.37/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Nadia Noreen, Pakistan) | File 1 | File 2
Stage 2 | Peer review report_2 (Claudio Gambardella, Italy) | File 1 | NA
Stage 2 | Peer review report_3 (Hojat Rashidi Jahan, Iran) | File 1 | NA
Stage 2 | Peer review report_4 (Shan Sasidharan, India) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Stage 3 | Comment_Editor_2_v1 | File 1 | NA
Stage 3 | Comment_Editor_3_v1 | File 1 | NA
Stage 3 | Comment_Editor_4_v1 | File 1 | NA